ActBlue CEO Regina Wallace-Jones is scheduled to testify before the House Administration Committee on Wednesday, facing questions about whether the Democratic fundraising powerhouse accurately represented its fraud prevention practices to Congress. The hearing marks Wallace-Jones' first public appearance addressing allegations that the payment processor may have made false statements about how it screens overseas donors.
The Republican-led investigation into ActBlue has been ongoing since 2023, focusing on whether foreign money was routed through the platform into U.S. elections. Nonresident foreign nationals are generally prohibited from making political contributions to federal candidates, candidate committees and political action committees under federal law. House Committee Chairman Bryan Steil, R-Wis., has framed the probe as an effort to ensure that bad actors, including foreign actors, cannot exploit online fundraising platforms.
What the Right Is Saying
Republicans have pointed to reporting by The New York Times indicating that ActBlue's former outside counsel warned Wallace-Jones she may have made false statements to Steil's panel about its fraud screening practices. According to that report, attorneys found that some anti-fraud measures described to congressional investigators were not always followed as outlined.
Steil has sharply criticized ActBlue personnel for what he characterizes as a lack of full cooperation with the investigation. Five current and former ActBlue employees invoked their Fifth Amendment right against self-incrimination a combined 146 times when called to testify before the committee. "The goal of this investigation remains the same: to ensure that federal law effectively stops bad actors," Steil wrote in his letter accompanying the subpoena request.
What the Left Is Saying
ActBlue representatives have maintained that they have not made false statements to Congress and point to their cooperation with investigators. The organization argues that it voluntarily agreed in May to appear before the committee before any subpoena was issued. In a June 2025 letter to Steil's committee, ActBlue acknowledged strengthening certain fraud prevention practices, which supporters note demonstrates the platform's commitment to improving its systems.
Democratic allies have characterized the Republican investigation as politically motivated, arguing that the timing and intensity of the probe serve campaign purposes rather than genuine regulatory concerns. Supporters note that ActBlue processes billions of dollars in donations for thousands of Democratic candidates and causes, making it a natural target for partisan scrutiny.
What the Numbers Show
The House Administration Committee's investigation has been ongoing since 2023, examining ActBlue's payment processing and fraud prevention practices for overseas donors. Five current and former ActBlue employees invoked their Fifth Amendment rights a combined 146 times when their testimony was subpoenaed by Steil's panel. The committee has requested documents from five members of ActBlue's Board of Directors, with a compliance deadline of June 16. Two unions affiliated with ActBlue raised concerns about "a growing pattern of volatility and toxicity" among leadership in communications to the board.
The Bottom Line
Wallace-Jones' testimony Wednesday could prove pivotal for both sides. Republicans are seeking clarity on whether discrepancies between ActBlue's public statements and internal practices constitute misleading Congress, while Democrats will likely emphasize the platform's cooperation and improvements to its fraud screening. Steil has also expanded the investigation beyond Wallace-Jones to include board members, suggesting the probe will continue regardless of Wednesday's outcome. The involvement of House Judiciary Committee Chairman Jim Jordan and Oversight Committee Chairman James Comer indicates broader Republican interest in the matter.